These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7238766)

  • 1. The synthesis of enantiomers of 4-ketocyclophosphamide.
    Misiura K; Pankiewicz K; Stec WJ; Jarman M
    Experientia; 1981 Mar; 37(3):216-7. PubMed ID: 7238766
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synthesis of 4-ureidooxycyclophosphamide (author's transl)].
    Niemeyer U; Scheffler G; Nonnenmacher G
    Arzneimittelforschung; 1982; 32(5):478-80. PubMed ID: 7201822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide analogues.
    Zon G
    Prog Med Chem; 1982; 19():205-46. PubMed ID: 6758039
    [No Abstract]   [Full Text] [Related]  

  • 4. Analytical and preparative high-performance liquid chromatographic separation of the enantiomers of ifosfamide, cyclophosphamide and trofosfamide and their determination in plasma.
    Masurel D; Wainer IW
    J Chromatogr; 1989 May; 490(1):133-43. PubMed ID: 2760146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and identification of a stabilized derivative of aldophosphamide, a major metabolite of cyclophosphamide.
    Struck RF
    Cancer Res; 1974 Nov; 34(11):2933-5. PubMed ID: 4417999
    [No Abstract]   [Full Text] [Related]  

  • 6. 4-Ketocyclophosphamide, a metabolite of cyclophosphamide. Formation, chemical and biological properties.
    Hohorst HJ; Ziemann A; Brock N
    Arzneimittelforschung; 1971 Aug; 21(8):1254-7. PubMed ID: 5110030
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation and identification of a metabolic intermediate in the selective dechloroethylation of one of the four stereoisomers of 4-methylcyclophosphamide.
    Abel G; Cox PJ; Farmer PB; Haskins NJ; Jarman M; Meral K; Stec WJ
    Cancer Res; 1978 Aug; 38(8):2592-9. PubMed ID: 667853
    [No Abstract]   [Full Text] [Related]  

  • 8. Aldophosphamide: synthesis, characterization, and comparison with "Hohorst's aldophosphamide".
    Struck RF
    Cancer Treat Rep; 1976 Apr; 60(4):317-9. PubMed ID: 1277207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cyclophosphamide (NSC-26271) metabolites and related derivatives by field-desorption and electron-impact mass spectrometry.
    Przybylski M; Ringsdorf H; Voelcker G; Draeger U; Peter G; Hohorst HJ
    Cancer Treat Rep; 1976 Apr; 60(4):509-16. PubMed ID: 1277228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. I. Antitumour effect of cyclophosphamide and ifosfamide enantiomers.
    Paprocka M; Kuśnierczyk H; Budzyński W; Rak J; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):275-84. PubMed ID: 3592931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cyclophosphamide and 4-ketocyclophosphamide on mouse limb development.
    Manson JM; Smith CC
    Teratology; 1977 Jun; 15(3):291-9. PubMed ID: 882918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The X-ray structure and absolute configuration of the anticancer drug (+)-4-ketocyclophosphamide.
    Gdaniec M; Adamiak DA; Misiura K
    Acta Biochim Pol; 1989; 36(3-4):205-13. PubMed ID: 2485997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray crystallographic studies of cyclophosphamide (NSC-26271) derivatives.
    Camerman A; Smith HW; Camerman N
    Cancer Treat Rep; 1976 Apr; 60(4):517-22. PubMed ID: 1277229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. II. Antiproliferative activity of cyclophosphamide and ifosfamide enantiomers.
    Paprocka M; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):285-91. PubMed ID: 3592932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution nuclear magnetic resonance investigations of the chemical stability of cyclophosphamide and related phosphoramidic compounds.
    Zon G; Ludeman SM; Egan W
    J Am Chem Soc; 1977 Aug; 99(17):5785-95. PubMed ID: 886123
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on 4-hydroperoxycyclophosphamide (NSC-181815): a simple preparation method and its application for the synthesis of a new class of "activated" sulfur-containing cyclophosphamide (NSC-26271) derivatives.
    Peter G; Wagner T; Hohorst HJ
    Cancer Treat Rep; 1976 Apr; 60(4):429-35. PubMed ID: 1277218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iminocyclophosphamide as a chemically reactive metabolite of cyclophosphamide.
    Fenselau C; Lehman JP; Myles A; Brandt J; Yost GS; Friedman OM; Colvin OM
    Drug Metab Dispos; 1982; 10(6):636-40. PubMed ID: 6130913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.
    Friedman OM; Wodinsky I; Myles A
    Cancer Treat Rep; 1976 Apr; 60(4):337-46. PubMed ID: 1277209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microsomal metabolism of some analogues of cyclophosphamide: 4-methylcyclophosphamide and 6-methylcyclophosphamide.
    Cox PJ; Farmer PB; Jarman M
    Biochem Pharmacol; 1975 Mar; 24(5):599-606. PubMed ID: 1125063
    [No Abstract]   [Full Text] [Related]  

  • 20. The comparative pharmacology of cyclophosphamide and ifosfamide.
    Colvin M
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):2-7. PubMed ID: 6761865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.